Technology Results for "Biotechnology"

Available Technologies

00HSC027 The Hyaluronan Receptor for Endocytosis (HAS) and Uses Thereof

00HSC016 In Vitro, Tissue Engineered, Regenerated Urinary Tract Organs

01HSC024 Derivatives of Clostridium septicum alpha toxin with potential for vaccine development

02HSC015 The Use of Distal Ileum Submucosa for Urinary Bladder Regeneration

03HSC018 Discovery of a Novel Enzyme that Enhances the Proficiency of a2-antiplasmin as an Inhibitior of Blood Clot Removal

04HSC053 Comprehensive Detection and Identification of Tumor-specific Sequences and Potential Changes in Immune Responses in Circulating Cells of Peripheral Blood Using Suppression Subtractive Hybridization-based Differential Gene Expression Analysis

05HSC006 661W A Cone Photoreceptor Cell Line

05HSC049 Vaccine against West-Nile Virus

06HSC003 Identification of Drugs to Target Suppressed Cancer Cells

07HSC007 A New Method for Screening for Autoantibodies Against Receptors

06HSC040 Blood Test for Pancreatic Cancer

06HSC028 Interferon Gamma Inhibition of Herpes Virus Infection

06HSC026 Biochemical Diagnosis of 'Refractory' Chronic Periodontitis

06HSC017 Use of Biofilm Lysine Decarboxylase Activity to Detect 'Refractory' Chronic Peridontitis

06HSC014 Role of Cosmc in Human Diseases and Disorder

06HSC013 Enzyme Immunoassay for Complement Fixing Anti-Phospholipid Antibodies

06HSC007 Generalizable Method for Searching for Assembly-Directed Antiviral Compounds

06HSC006 A Serine Kinase Inhibitor as a Novel Anthrax Therapeutic

05HSC039 Induction of Apoptosis Through Regulation of Gene Expression

05HSC038 Regulation of the Hepatocyte Nuclear Factor-4 (HNF-4) Receptor

05HSC040 Prevention of Cancer by Reversing Abnormal Differentiation and Inducing Apoptosis

05HSC037 Inhibition of Angiogenesis and Expression of Genes Involved in Blood Vessels

05TUL025 Non-Human Model for Human Endometriosis

05TUL024 Diagnostic Method for Screening Complement Regulatory Protein Levels

05TUL023 Diagnostic Method for Screening Complement Regulatory Protein levels to Predict Spontaneous Abortion

99NOR006 Microencapsulated Plasminogen Activator

97NOR010 New Fusion Protein Systems Designed to Increase Soluble Cytoplasmic Expression of Heterologous Proteins in E. Coli

05HSC047 Nanoceria Particles Provide Neuronal Protection in Retinal Cells

05HSC045 Versatile Derivatization of Glycans for Glycomic Analysis

05HSC043 Novel Heteroarotinoids as Potential Inhibitors of Human PKD

05HSC042 A Single Primer-Extension Based Assay for the Detection of DNA Damage

07NOR004 New Cancer Treatment Aimed at Destruction of Cancer Tumors

03NOR036 Cytotoxic Agent Targeted to Cancer Cells

02NOR022 Development of Intracellular Inhibitors of Bacterial Toxins

07HSC024 Method of targeted depletion of gastrointestinal and cancer stem cells

07HSC017 Use of Self Compacted DNA Nanoparticles for Ocular Diseases

07HSC013 Determination of Rab5 Activity (Rab5-GTP level) in the Cell by Effector Pull-Down Assay

05HSC050 Identification of Tumor-Specific Sequences and Alterations in Immune Responses in Peripheral Blood Circulating Cells of Cancer-Bearing Patients for Cancer Screening

04HSC058 Sindbis Virus and Related Plus-Stranded RNA Viruses as Oncolytic Reagents for Cancer Therapy

03HSC019 Detection of a Single Nucleotide Polymorphism that Results in Arg6Trp in a2AP

04HSC001 A Cell-Based Assay for Small Molecule Inhibitors of the Mitotic Spindle Checkpoint/Metaphase Checkpoint Pathway

04HSC007 Gene Expression by Retinal Capillary Pericytes/Smooth Muscle Cells after Exposure to Modified Low Density Lipoproteins (LDL)

Licensed Technologies

04HSC034 Mixed-Bed Lectin Chromatography

05HSC012 Development and Use of a Chimeric Protein for Therapy of Bleeding Disorders and Cancer

07HSC034 Obtain interpretable DNA sequence immediately adjacent to a synthetic DNA sequencing primer

98HSC021 Lysine Decarboxylase Inhibitors for Prevention and Treatment of Periodontal Disease